Other studies have explored the use of STING agonists with mRNA in lymph node‐targeting nanoparticles, demonstrating robust tumor‐specific immune responses and long‐term memory in murine models.[60] Although our current study did not include a STING agonist, it would be of interest to compare its immunomodulatory effects with 3M‐052, including considering their combined use. The gene discussed is STING1; the disease is neoplasm.